Valuation: Enovis Corporation

Market Cap 1.51B 1.32B 1.22B 1.13B 2.12B 145B 2.17B 14.59B 5.72B 71.03B 5.68B 5.55B 245B P/E 2026 *
219x
P/E 2027 * 27.2x
Enterprise Value 2.71B 2.37B 2.19B 2.02B 3.81B 261B 3.88B 26.16B 10.25B 127B 10.17B 9.95B 439B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.05x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-6.10%
1 week-3.41%
Current month+19.08%
1 month+13.07%
3 months-1.79%
6 months+1.57%
Current year-7.47%
1 week 23.32
Extreme 23.315
27.08
1 month 19.14
Extreme 19.14
27.08
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-6.10%-3.41%-22.87%-62.22% 1.51B
-6.15%-5.66%-20.54%+2.86% 127B
-3.51%-2.41%-0.45%-5.59% 13.02B
-0.18%+1.19%+46.32%+92.76% 8.97B
-0.52%-0.94%-50.84%-73.25% 3.86B
+2.97%+6.03%+23.68%+49.54% 2.74B
+0.47%-7.61%-18.11%-29.75% 1.66B
+3.48%+1.50%-2.95%-21.21% 1.59B
-4.30%-1.86%-62.27%-84.93% 1.48B
Average -1.54%+1.76%-12.00%-14.64% 17.99B
Weighted average by Cap. -5.14%+2.05%-15.40%+4.15%

Financials

2026 *2027 *
Net sales 2.34B 2.05B 1.9B 1.75B 3.3B 225B 3.36B 22.64B 8.87B 110B 8.8B 8.61B 380B 2.47B 2.16B 2B 1.84B 3.47B 237B 3.54B 23.82B 9.33B 116B 9.26B 9.06B 400B
Net income 2.96M 2.59M 2.4M 2.21M 4.16M 285M 4.25M 28.59M 11.2M 139M 11.12M 10.87M 480M 54.22M 47.48M 43.89M 40.49M 76.24M 5.22B 77.76M 524M 205M 2.55B 204M 199M 8.8B
Net Debt 1.2B 1.05B 969M 894M 1.68B 115B 1.72B 11.56B 4.53B 56.28B 4.5B 4.4B 194B 1.07B 933M 863M 796M 1.5B 103B 1.53B 10.3B 4.03B 50.1B 4B 3.91B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
14/07/26 USD 24.65 -6.10% 857,416
13/07/26 USD 26.25 +1.94% 914,625
10/07/26 USD 25.75 +2.10% 768,242
09/07/26 USD 25.22 +6.73% 1,940,894
08/07/26 USD 23.63 -7.41% 1,213,833
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.25USD
Average target price
40.73USD
Spread / Average Target
+55.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock